CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale CHIEF OPERATING OFFICER sold 48,300 shares at an average $27.99 ($1,351,762)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 132,500 shares at an average $26.23 ($3,476,014)
- 4 Planned sale Director sold 13,920 shares at an average $25.02 ($348,281)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 13,000 shares (option exercise)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $16.84 ($84,206)
- 4 Option exercise Director acquired 15,958 shares (option exercise)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
Page 6 of 40 · 798 filings